Ascentage Pharma Group International (AAPG)
$15.06-1.63%Close
SELLCRISIS · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $350M
- Beta
- 0.66
- P/E (TTM)
- -6.45
- Short % float
- 0.14%
- Days to cover
- 1.5
- SI change
- -53.4%
- 1W
- -6.40%
- 1M
- -8.23%
- vs SPY 1W
- -6.26%
- vs SPY 1M
- -10.73%
Industry peers
FMP comparable companies · ranked by market cap
- TNGXSELLTango Therapeutics, Inc.$3.9BRECOVERYQ 23$23.81-8.07%
- IDYASELLIDEAYA Biosciences, Inc.$3.4BBEARQ 25$36.11-4.99%
- ZLABSELLZai Lab Limited$2.8BCRISISQ 8$24.99-6.06%
- NRIXSELLNurix Therapeutics, Inc.$2.3BBEARQ 11$22.35-0.14%
- NUVBSELLNuvation Bio Inc.$1.7BCRISISQ 4$5.00-3.67%
- ANLSELLAdlai Nortye Ltd.$829MCRISISQ 10$15.62-17.30%
- AVBPSELLArriVent BioPharma, Inc.$779MCRISISQ -6$16.73-2.25%
- VSTMBUYVerastem, Inc.$736MRECOVERYQ 4$8.38-9.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 4
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-92.3%
REV YoY-
ROE-153.8%
EPS YoY-
ROA-44.7%
GROSS82
OP-219
NET-229
[VALUATION]
P/E TTM-6.45
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B16.87
P/FCF-
EV/EBITDA-7.35
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E376.46
ALTMAN Z-
CURR RATIO1.22
ND/EBITDA-
BETA0.66
Company news
FAQ
- What is LOPJLB’s current signal on AAPG?
- LOPJLB’s latest quantitative signal on Ascentage Pharma Group International (AAPG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AAPG in?
- Ascentage Pharma Group International (AAPG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Ascentage Pharma Group International (AAPG) do?
- Based in Suzhou, China, Ascentage Pharma Group International is a biotechnology firm primarily focused on clinical-stage development. The company is dedicated to discovering and advancing therapeutic solutions for a range of medical conditions, including various cancers, chronic hepatitis B virus (HBV) infections, and age-related ailments. A cornerstone of its product pipeline is HQP1351, a BCR…